4.1 Review

Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma

Related references

Note: Only part of the references are listed.
Review Oncology

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Sattva S. Neelapu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Biotechnology & Applied Microbiology

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

James N. Kochenderfer et al.

MOLECULAR THERAPY (2017)

Article Medicine, General & Internal

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Stephen J. Schuster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

S. S. Neelapu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Multidisciplinary Sciences

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor

Chia-Yung Wu et al.

SCIENCE (2015)

Article Cell Biology

Adoptive cellular therapy: A race to the finish line

Carl H. June et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Review Oncology

Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors

James N. Kochenderfer et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2013)

Article Medicine, General & Internal

Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia

Stephan A. Grupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Christian Gisselbrecht et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Medicine, General & Internal

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

Ganesh Suntharalingam et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Pharmacology & Pharmacy

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

D Czock et al.

CLINICAL PHARMACOKINETICS (2005)

Article Biotechnology & Applied Microbiology

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor

J Maher et al.

NATURE BIOTECHNOLOGY (2002)